Human TREML2 HEK293 Overexpression Lysate
Cat: 11655-H08HL
Cat: 11655-H08HL
Price:
Size:
Number:
Human TREML2 HEK293 Overexpression Lysate: Product Information
Product Description
This Human TREML2 overexpression lysate was created in HEK293 Cells and intented for use as a Western blot (WB) positive control. Purification of TREML2 protein (Cat: 11655-H08H) from the overexpression lysate was verified.
Expression Host
HEK293 Cells
Species
Human
Sequence Information
A DNA sequence encoding the human TREML2 (NP_079083.2) extracellular domain (Met 1-Ser 268) was fused with a polyhistidine tag at the C-terminus.
Molecule Mass
The recombinant human TREML2 consists of 261 amino acids and has a predicted molecular mass of 28.5 kDa. In SDS-PAGE under reducing conditions, the apparent molecular mass of rh TREML2 is approximately 55-60 kDa due to glycosylation.
Human TREML2 HEK293 Overexpression Lysate: Usage Guide
Preparation Method
Cell lysate was prepared by homogenization of the over-expressed cells in ice-cold modified RIPA Lysis Buffer with cocktail of protease inhibitors (Sigma). Cell debris was removed by centrifugation. Protein concentration was determined by Bradford assay (Bio-Rad protein assay, Microplate Standard assay). The cell lysate was boiled for 5 min in 1 x SDS loading buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% b-mercaptoethanol, and lyophilized.
Lysis Buffer
Modified RIPA Lysis Buffer: 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% SDS, 1% Sodium deoxycholate, 1mM PMSF.
Recommend Usage
1. Centrifuge the tube for a few seconds and ensure the pellet at the bottom of the tube.
2. Re-dissolve the pellet using 200μL pure water and boil for 2-5 min.
Sample Buffer
1 X Sample Buffer (1 X modified RIPA buffer+1 X SDS loading buffer).
Stability & Storage
Store at 4℃ for up to twelve months from date of receipt. After re-dissolution, aliquot and store at -80℃ for up to twelve months. Avoid repeated freeze-thaw cycles.
Application
Western Blot (WB)
Optimal dilutions/concentrations should be determined by the end user.
Optimal dilutions/concentrations should be determined by the end user.
Human TREML2 HEK293 Overexpression Lysate: Alternative Names
Human C6orf76 Overexpression Lysate; Human dJ238O23.1 Overexpression Lysate; Human FLJ13693 Overexpression Lysate; Human MGC149715 Overexpression Lysate; Human MGC149716 Overexpression Lysate; Human TLT-2 Overexpression Lysate; Human TLT2 Overexpression Lysate; Human UNQ6268/PRO20473 Overexpression Lysate
TREML2 Background Information
Trem-like transcript 2 protein, also known as Triggering receptor expressed on myeloid cells-like protein 2, TREML2 and TLT2, is a single-pass type I membrane protein which contains oneIg-like V-type (immunoglobulin-like) domain. TREML2 is detected in cultured B cells, T cell leukemia and monocyte leukemia. TREML2 is expressed constitutively on CD8 T-cells and induced on CD4 T-cells after activation. TREML2 is a cell surface receptor that may play a role in the innate and adaptive immune response. TREML2 acts as a counter-receptor for CD276 and interaction with CD276 on T-cells enhances T-cell activation. Murine B7-H3 specifically bound to Triggering receptor expressed on myeloid cells (TREM)-like transcript 2 (TLT-2, TREML2). TREML2 was expressed on CD8(+) T cells constitutively and on activated CD4(+) T cells. Stimulation with B7-H3 transfectants preferentially up-regulated the proliferation and IFN-gamma production of CD8(+) T cells. Transduction of TREML2 into T cells resulted in enhanced IL-2 and IFN-gamma production via interactions with B7-H3. There maybe a direct interaction between B7-H3 and TREML2 that preferentially enhances CD8(+) T cell activation.
Full Name
triggering receptor expressed on myeloid cells like 2
References
- Mungall A.J. et al., 2003, Nature. 425: 805-11.
- Clark HF. et al., 2003, Genome Res. 13: 2265-70.
- The MGC Project Team. et al., 2004, Genome Res. 14:2121-7.
- Hashiguchi M., et al., 2008, Proc. Natl.Acad. Sci. USA.105:10495-500.
- Leitner,J. et al., 2009, Eur J Immunol. 39 (7):1754-64.
